PRELUDE CAPITAL MANAGEMENT, LLC - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 36 filers reported holding AUTOLUS THERAPEUTICS PLC in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q4 2019$6,000
-14.3%
460
-14.8%
0.00%
Q3 2019$7,000
-22.2%
540
-8.5%
0.00%
Q2 2019$9,000
-25.0%
590
+52.5%
0.00%
-100.0%
Q1 2019$12,000
-7.7%
387
-1.8%
0.00%0.0%
Q4 2018$13,000
-98.6%
394
-98.7%
0.00%
-98.2%
Q3 2018$945,000
+189.9%
30,812
+153.3%
0.06%
+161.9%
Q2 2018$326,00012,1660.02%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q1 2019
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,283,966$15,166,0001.40%
Sio Capital Management, LLC 591,870$3,930,0000.98%
TFG Asset Management GP Ltd 2,500,000$16,600,0000.90%
Ikarian Capital, LLC 1,356,048$9,004,0000.73%
SABBY MANAGEMENT, LLC 400,050$2,656,0000.37%
Nantahala Capital Management 1,793,500$11,909,0000.34%
Regency Capital Management Inc.\DE 57,000$378,0000.29%
Eversept Partners, LP 473,074$3,141,2110.21%
MYDA Advisors LLC 85,000$564,0000.14%
Henry James International Management Inc. 54,047$359,0000.10%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders